Status:
COMPLETED
Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
18-35 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare bleeding pattern of contraceptive Yasmin 20 to a marketed comparator.
Eligibility Criteria
Inclusion
- Healthy female volunteer aged 18-35,
- Smokers 18-30
Exclusion
- Contraindications for using hormonal contraceptives
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
453 Patients enrolled
Trial Details
Trial ID
NCT00624130
Start Date
March 1 2004
End Date
June 1 2005
Last Update
December 31 2014
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Horn, Austria, 3580
2
Leibnitz, Styria, Austria, 8430
3
Mödling, Austria, 2340
4
Sankt Pölten, Austria, 3100